The Use of Hepatitis C Positive Kidneys in Hepatitis C Negative Kidney Transplant Recipients
Running, not enrolling · Phase 2
Conditions studied: Kidney Transplantation, Hepatitis C
In brief
This is an open-label, pilot trial to test the safety and efficacy of transplantation of kidneys from hepatitis C seropositive non-viremic (HCV Ab+/NAT-) and HCV seropositive viremic (HCV Ab+/NAT+) donors to HCV seronegative recipients on the kidney transplant waitlist. Treatment and prophylaxis will be administered using a transmission-triggered approach for the first scenario (HCV Ab+/NAT- donors, arm 1) and a prophylaxis approach for the later scenario (HCV Ab+/NAT+ donors, arm 2).
Key facts
- Study ID
- NCT03809533
- Run by
- Amit D Tevar, MD
- People needed
- 30
- Starts
- 2019-05-29
- Expected to finish
- 2026-04-01
- Last updated by the study team
- 2025-11-06
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- UPMC — Pittsburgh, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.